Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.
Press releases published on September 14, 2025
プロダクトライフ・グループ (ProductLife Group)、日本で現地密着の専門知識と強化されたクライアントサポートを提供するために事業を拡大
パリ発, Sept. 15, 2025 (GLOBE NEWSWIRE) -- プロダクトライフ・グループ (PLG) は、クライアントのニーズと市場ニーズの変化に応えるという同社のコミットメントを強化するために、日本に新たなオフィスを開設したと発表しました。 このオフィス設立により、キャパシティが強化され、地域およびグローバルなネットワークが拡大、シームレスなコラボレーションが可能となり、さらなる市場やサービスをサポートすることが可能となります。 …
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
VALENCIA, Calif., Sept. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced it has received the CE Mark under the European Union …
Performer 8 Male Enhancement “Launch” The Herbal Performance Enhancer Non Prescription ED Pills for Men 2025 over the counter by Performer 8
NEW YORK , Sept. 14, 2025 (GLOBE NEWSWIRE) -- New York City, NY, September 14, 2025, Performer 8 introduced advanced Male enhancement and testosterone booster supplements, which have always been popular among men who wish to achieve long-lasting erections …
TestoPrime Launch: Advanced Testosterone Booster for Men Over 50’ For Muscle Gain | Does TestoPrime Actually Work?
new york , Sept. 14, 2025 (GLOBE NEWSWIRE) -- New York City, NY, September 14, 2025, TestoPrime introduced an effective testosterone booster for men over 40s and 50s seeking a proven, safe, and powerful way to restore youthful energy, muscle, and vitality, …
Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management
SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) -- At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in AI-driven Internet healthcare solutions, announced the release of its proprietary “XingShi” …
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced …